BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China

Innovent Secures China Approval For Jaypirca In Previously Treated CLL And SLL

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...

March 03, 2026 | News

SystImmune And Bristol Myers Squibb Report Dual PFS And OS Success For Iza Bren In Phase III TNBC Trial

Izalontamab brengitecan (Iza-bren) met its dual primary endpoints of progression free survival (“PFS”) and overall survival (“OS”...

March 02, 2026 | News

WuXi XDC And Earendil Labs Forge Strategic Alliance To Advance Next Generation AI Designed ADCs

WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializin...

March 02, 2026 | News

Sanyou Bio Completes Strategic Equity Restructuring With Liferiver Biotech And Yanghe Investment

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio"), a biotech company powered by super-trillion-molecule libraries and AI-driven technologies,&n...

February 26, 2026 | News

Antengene And Junshi Biosciences Enter Clinical Collaboration To Advance ATG 037 And JS207 Combination In Solid Tumors

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, ...

February 26, 2026 | News

iRegene Advances Global Cell Therapy Programme With Key Parkinson’s And MSA Clinical Milestones

The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline into key clinical...

February 25, 2026 | News

Sciwind Biosciences And Pfizer China Forge Strategic Commercialisation Pact For Ecnoglutide In Mainland China

Hangzhou Sciwind Biosciences Co., Ltd. announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a n...

February 25, 2026 | News

CStone Secures UK MHRA Approval For Sugemalimab In Stage III Non Small Cell Lung Cancer

Following approval by the European Commission (EC), sugemalimab has received a new indication approval from the UK Medicines and Healthcare products...

February 24, 2026 | News

YolTech Reports Positive Interim Data For YOLT 202 In Alpha 1 Antitrypsin Deficiency

Single dose of YOLT-202 led to rapid, robust and dose-dependent increases in AAT levels to normal range Single dose of YOLT-202 was well tolerated with ...

February 23, 2026 | News

Bon Natural Life Establishes Joint Laboratory To Advance Bio Manufactured Natural Ingredients

Bon Natural Life Limited (Nasdaq: BON) ("BON"or the "Company"), a leading bio-ingredient provider for the natural health and personal care industries, anno...

February 19, 2026 | News

CARsgen Therapeutics Advances Commercial CAR T Cell Manufacturing With Shanghai Strategic Partnership

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that through its in...

February 17, 2026 | News

Innovent Advances IBI354 Into Pivotal Phase Three Trial For HER2 Positive Advanced Breast Cancer

Innovent Biologics, Inc. ("Innovent",HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medi...

February 16, 2026 | News

Alphamab Oncology Advances JSKN003 Into Phase III Trial For HER2 Positive Advanced Colorectal Cancer

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005...

February 16, 2026 | News

Ribo And Ribocure Sign Global Licensing Deal With Madrigal For Six siRNA Programmes In MASH

Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") announced that they have entere...

February 13, 2026 | News

Stay Connected